Omada Health (OMDA) began trading on the Nasdaq Global Select Market today, opening at $23 per share, above its IPO price of $19. The stock is currently trading around $26.50, representing a nearly 40% increase from its IPO price, after the company offered 7,900,000 shares of common stock. Morgan Stanley, Goldman Sachs & Co. LLC, and J.P. Morgan served as the lead book-running managers for the offering.
Omada Health (OMDA) commenced trading on the Nasdaq Global Select Market with a strong debut, as its shares opened at $23, exceeding the initial public offering price of $19 per share. The stock subsequently surged to $26.50 per share, marking a nearly 40% increase from the IPO price, indicating robust investor demand. This positive market reception is supported by a "strongly positive" sentiment score of 0.8 and an "optimistic" tone. The offering comprised 7,900,000 shares of common stock, with underwriters—led by Morgan Stanley, Goldman Sachs & Co. LLC, and J.P. Morgan—granted a 30-day option to purchase up to an additional 1,185,000 shares. This successful IPO in the virtual healthcare sector underscores continued interest in "Healthcare & Biotech" and "Technology & Innovation" themes, particularly within the public markets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment
